Main View
This view is used for searching all possible sources.
First Page Previous Page 1 Next Page Last Page
 
1
Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
2010-09-02

BackgroundInflammation plays an important role in the pathophysiology of both atherosclerosis and type 2 diabetes and some inflammatory markers may also predict the risk of developing type 2 diabetes. The aims of the present study were to assess a potential association between circulating levels of inflammatory markers and hyperglycaemia measured during an acute ST-elevation myocardial infarction ...

PubMed Central

2
Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
2011-07-29

BackgroundPatients with acute myocardial infarction and newly detected abnormal glucose regulation have been shown to have a less favourable prognosis compared to patients with normal glucose regulation. The importance and timing of oral glucose tolerance testing (OGTT) in ...

PubMed Central

3
High Prevalence of Diabetes and Pre-Diabetes in Adults With Williams Syndrome
2010-05-15

A standard oral glucose tolerance test (OGTT) was administered to 28 adults with Williams syndrome (WS). Three quarters of the WS subjects showed abnormal glucose curves, meeting diagnostic criteria for either diabetes or the pre-diabetic state of impaired glucose tolerance. Fasting mean ...

PubMed Central

4
New ways in which GLP-1 can regulate glucose homeostasis
2005-12-01

Glucagon-like peptide�1 (GLP-1) has a diverse set of peripheral actions which all serve to promote enhanced glucose tolerance, and for this reason it has become the basis for new treatments for type 2 diabetes. In this issue of the JCI, Knauf et al. provide clear evidence that GLP-1 signaling in the CNS is also linked to the control of peripheral glucose ...

PubMed Central

5
Regulation of insulin secretion: insights from engineered beta-cell lines.
2004-04-01

Abnormalities in insulin secretion are involved in a number of diseases, including type 1 and type 2 diabetes, persistent hyperinsulinemic hypoglycemia of infancy, and insulinoma. Understanding the mechanisms that regulate insulin secretion may allow the development of new therapies for these diseases as well as contribute to our ability to engineer ...

PubMed

6
Research on Aging Project in Iceland: Second Stage
2011-05-05

Atherosclerosis; Osteoporosis; Obesity; Glucose Abnormalities; Alzheimer's Disease; Vascular Dimentia

ClinicalTrials.gov

7
Pravastatin for Hyperlipidaemia in HIV.
2006-06-08

HIV Infections; Lipid Metabolism; Glucose Metabolism; Metabolic Abnormality; Lipodystrophy; Cardiovascular Disease

ClinicalTrials.gov

8
Detailed Physiologic Characterization Reveals Diverse Mechanisms for Novel Genetic Loci Regulating Glucose and Insulin Metabolism in Humans
2010-05-25

OBJECTIVERecent genome-wide association studies have revealed loci associated with glucose and insulin-related traits. We aimed to characterize 19 such loci using detailed measures of insulin processing, secretion, and sensitivity to help elucidate their role in regulation of glucose control, insulin secretion and/or action.RESEARCH ...

PubMed Central

9
[Fasting hyperglycaemia and polymorphism in glucokinase promoter (rs1799884).
2011-06-20

Glucokinase is one of the most important regulators of fasting glucose levels. There are several mutations in the glucokinase gene (GCK) which are linked with monogenic diabetes. Recently, a polymorphism in its promoter has been described, which is associated with impaired fasting glucose levels. We present a 7 years and 7 months old ...

PubMed

First Page Previous Page 1 Next Page Last Page